Marinomed Biotech AG / ATMARINOMED6
26.09.2024 - 09:15:03Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Marinomed Biotech AG 26.09.2024 / 09:15 CET/CEST Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 24.9.2024 Overview ? Notification made after deadline Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights) 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Event changing the breakdown of voting rights 3. Person subject to notification obligation Name: Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit City: 1016 Wien Country: Österreich 4. Name of shareholder(s): 5. Date on which the threshold was crossed or reached: 18.9.2024 6. Total positions
8. Information in relation to the person subject to the notification obligation: ? Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. ? Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity: 9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Per 18. September 2024 erfolgte eine 10%ige Kapitalerhöhung des Grundkapitals der Marinomed AG (ATMARINOMED6). Die Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit, hat an dieser Kapitalerhöhung nicht teilgenommen und hält unverändert 62.916 Aktien der Gesellschaft. Ihr Anteil an der Marinomed AG reduzierte sich dadurch von 4,08% auf 3,71%. Wien am 24.9.2024 26.09.2024 CET/CEST |
Language: | English |
Company: | Marinomed Biotech AG |
Hovengasse 25 | |
2100 Korneuburg | |
Austria | |
Internet: | www.marinomed.com |
End of News | EQS News Service |
|